AMG 386, a Selective Angiopoietin 1/2-Neutralizing Peptibody, Inhibits Angiogenesis in Models of Ocular Neovascular Diseases-Reference-Cited by-同舟云学术

AMG 386, a Selective Angiopoietin 1/2-Neutralizing Peptibody, Inhibits Angiogenesis in Models of Ocular Neovascular Diseases

Published:2012-04-24 Issue:4 Volume:53 Page:2170
ISSN:1552-5783
Container-title:Investigative Opthalmology & Visual Science
language:en
Short-container-title:Invest. Ophthalmol. Vis. Sci.

Author:

Oliner Jonathan D.¹,Bready James¹,Nguyen Linh¹,Estrada Juan¹,Hurh Eunju¹,Ma Hongjin¹,Pretorius James¹,Fanslow William¹,Nork T. Michael¹,Leedle Robert A.¹,Kaufman Stephen¹,Coxon Angela¹

Affiliation:

1. Departments of 1Oncology Research, 2Pharmacokinetics and Drug Metabolism, and 3Pathology, Amgen Inc., Thousand Oaks, California; 4Department of Oncology, Amgen Inc., Seattle, Washington; Comparative Ophthalmic Research Laboratories, University of Wisconsi

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Subject

General Medicine

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Types and Applications of Peptibodies;International Journal of Peptide Research and Therapeutics;2023-12-27

2. Sunitinib resistance in renal cell carcinoma: From molecular mechanisms to predictive biomarkers;Drug Resistance Updates;2023-03

3. ANGPTL4 influences the therapeutic response of patients with neovascular age-related macular degeneration by promoting choroidal neovascularization;JCI Insight;2022-07-08

4. Dual-acting therapeutic proteins for intraocular use;Drug Discovery Today;2021-01

5. Rapid Development of Glaucoma Via ITV Nonselective ANGPT 1/2 Antibody: A Potential Role for ANGPT/TIE2 Signaling in Primate Aqueous Humor Outflow;Investigative Opthalmology & Visual Science;2019-10-01